| __timestamp | Supernus Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 2999000 |
| Thursday, January 1, 2015 | 89204000 | 10393000 |
| Friday, January 1, 2016 | 106010000 | 15994000 |
| Sunday, January 1, 2017 | 137905000 | 26975000 |
| Monday, January 1, 2018 | 159888000 | 39509000 |
| Tuesday, January 1, 2019 | 158425000 | 48869000 |
| Wednesday, January 1, 2020 | 200677000 | 42510000 |
| Friday, January 1, 2021 | 304759000 | 46105000 |
| Saturday, January 1, 2022 | 377221000 | 50513000 |
| Sunday, January 1, 2023 | 336361000 | 51292000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Supernus Pharmaceuticals, Inc. and Wave Life Sciences Ltd. offer a fascinating study in contrasts. From 2014 to 2023, Supernus Pharmaceuticals saw a staggering 364% increase in SG&A expenses, peaking in 2022. In contrast, Wave Life Sciences Ltd. maintained a more modest growth of 1,610% over the same period, with a steady rise each year.
Supernus's expenses surged significantly in 2021, marking a 52% increase from the previous year, while Wave Life Sciences Ltd. showed a more consistent, albeit slower, growth pattern. This data highlights the strategic differences in cost management between the two companies, offering insights into their operational priorities and market strategies. Understanding these trends can provide investors and industry analysts with valuable perspectives on the financial strategies of these biotech players.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Dr. Reddy's Laboratories Limited and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Axsome Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? MorphoSys AG or Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights